Nicotinic acid sustained release tablets

Essential information:

Department: cardio cerebrovascular Department

[General Name] Niacin sustained release tablets

[Trade Name] Gozc

[Specification] 0.5g * 30 pieces / bottle * 300 bottles / piece

[Manufacturer] Hunan Sanjin Pharmaceutical Co., Ltd

[Approval No.] gyzz h20060727

[Unit] box

Product properties:

1. Three enterprises in China, new practice of low price medicine

2. Medical insurance class B, strictly controlled

3. Large development space and clear treatment effect

Details:

Nicotinic acid sustained-release tablets, indications for patients at high risk of cardiovascular disease due to hypercholesterolemia, the use of lipid-lowering drugs is only one of a variety of interventions. Nicotinic acid therapy can be used when dietary therapy and other non drug methods that limit saturated fatty acids and cholesterol intake are not effective. Before nicotinic acid treatment, the secondary causes of hypercholesterolemia (such as uncontrollable diabetes mellitus, hypothyroidism, nephrotic syndrome, albuminemia, obstructive liver disease, cholesterol level rise caused by other drugs, alcoholism) should be excluded, and the total cholesterol, HDL-C and triglyceride in blood should be measured.

[Usage and Dosage] take orally, 1000mg (two tablets 500mg) to 2000mg (two tablets 1000mg) once a day before going to bed

[Indications] this product can be used as an auxiliary treatment drug for exercise and diet control to reduce primary hypercholesterolemia.